Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy
Authors:
- Elizabeth M. RyanERElizabeth M. Ryan
- Ailín C. RogersARAilín C. Rogers
- Deborah A. McNamaraDMDeborah A. McNamara
- Robert D. MadoffRMRobert D. Madoff
- Desmond C. WinterDWDesmond C. Winter
- 1 April 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 259 (4) , 723-727
Abstract
The aim of this study was to evaluate the utility of reimaging rectal cancer post-CRT (chemoradiotherapy) with magnetic resonance (MR) imaging of the pelvis for local staging and computed tomography of thorax, abdomen, and pelvis (CT TAP) to identify distant metastases. The success of neoadjuvant CRT for locally advanced rectal cancer has changed an already complex management algorithm. There is no consensus whether patients should be restaged before surgery. Data from 5 institutions with prospectively maintained databases including patients who received neoadjuvant CRT for locally advanced rectal cancer were acquired. Only patients who had been staged pre- and post-CRT with MR imaging and CT TAP were included. MR findings were correlated with histopathological stage using weighted κ (kappa) statistics to test agreement, where a κ value of less than 0.5 was deemed unacceptable. A total of 285 patients fulfilled the criteria for the study; 84% had American Joint Committee for Cancer stage 3 disease pre-CRT, and the remainder had stage 2 disease. Fourteen patients did not proceed to surgery post-CRT-2 were observed as "complete responders," and the remainder either had unresectable disease or were unfit for surgery. MR imaging could not predict T stage (κ = 0.212) or nodal involvement (κ = 0.336). Most pertinently, MR imaging was unable to detect a complete pathological response (κ = 0.021), nor could it discriminate T4 disease (κ = 0.445). CT TAP restaging altered management in 6.7% of patients, who had metastatic disease. MR reimaging using standard protocols is of limited value in determining surgical approaches; a better modality of local restaging is required.Keywords
This publication has 30 references indexed in Scilit:
- Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancerBritish Journal of Surgery, 2012
- The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapyBritish Journal of Surgery, 2012
- Systematic review of outcomes after intersphincteric resection for low rectal cancerBritish Journal of Surgery, 2012
- A prospective analysis of patient outcome following treatment of T3 rectal cancer with neo-adjuvant chemoradiotherapy and transanal excisionInternational Journal of Colorectal Disease, 2011
- Local staging of rectal cancer: A review of imagingJournal of Magnetic Resonance Imaging, 2011
- The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007Annals of Oncology, 2008
- Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Local Excision of T2 and T3 Rectal Cancers After Downstaging ChemoradiationAnnals of Surgery, 2001
- Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999